BioSpace News Archive

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders, today announced expanded support for the Epilepsy Foundation to contribute to nationwide efforts in overcoming the challenges of epilepsy

Noteworth, a first-of-its-kind Digital Healthcare platform for modernizing Digital Medicine delivery operations, today announced a $5 million oversubscribed seed funding round led by Laconia Capital Group with participation from Draper Associates, Frontier Ventures, Techstars Ventures, Wavemaker360, Springtide Capital and others.

Karius, the world leader in liquid biopsy for infectious diseases, was named one of America’s most promising artificial intelligence companies by Forbes.

Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug Administration (FDA) has granted APG-2575, a novel Bcl-2 inhibitor being developed by

Neurogene Inc. , a company founded with a mission to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced Kenneth Huttner, M.D., Ph.D., has joined the company as Senior Vice President of Clinical Development, reporting to Effie Albanis M.D.,

Sinclair Research, a leading provider of nonclinical contract research services, today announced a strategic partnership with Bolder BioPATH, a premier provider of pharmacology and pathology services specializing in in vivo models of Rheumatoid Arthritis, Osteoarthritis, Inflammatory Bowel Disease, and other autoimmune and inflammation models. “Bolder BioPATH has developed a portfolio of high-quality pharmacology mode

Cerule International, a biotech company that developed the world’s first clinically proven and patented stem cell enhancer, has appointed Dr. Stanley Jacobs to provide a medical and educational perspective to assist customers in making informed health choices. Dr. Stanley Jacobs has a plethora of experience in Facial Plastic and Reconstructive Surgery. He has 16 years of higher education, including a BSc with Honors

Sensible Medical signs exclusive distribution agreement with Toul Meditech for Operio® Mobile and SteriStay® Clean Air Zone Systems.

SOSV and Mayfield today announced the creation of the Genesis Consortium, an alliance to promote human and planetary health, which will invest alongside SOSV into IndieBio startups at the pre-seed stage

ChemWerth Inc. , a leading supplier of generic Active Pharmaceutical Ingredients (APIs), filed a Drug Master File (DMF) with the Food and Drug Administration (FDA) for Clevidipine, making it the company’s 500 th DMF in its history. ChemWerth filed its first DMF in 1987 and continues to rank among world leaders for DMFs available for reference. The achievement of 500 DMFs represents ChemWerth’s staying power over